Veru to report fiscal 2021 first-quarter financial results, host conference call on february 10th

Miami, jan. 27, 2021 (globe newswire) -- veru inc. (nasdaq: veru), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, today announced that it will report financial results for its fiscal 2021 first quarter ended december 31, 2020, on wednesday, february 10, 2021 before the market opens.  veru's management will host a conference call that same day at 8 a.m. et to review the company's performance and to answer questions. the call will also be accessible via webcast.
VERU Ratings Summary
VERU Quant Ranking